+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Time-resolved quantitative phosphoproteomics: new insights into Angiotensin-(1-7) signaling networks in human endothelial cells



Time-resolved quantitative phosphoproteomics: new insights into Angiotensin-(1-7) signaling networks in human endothelial cells



Journal of Proteome Research 11(6): 3370-3381



Angiotensin-(1-7) [Ang-(1-7)] is an endogenous ligand of the Mas receptor and induces vasodilation, positive regulation of insulin, and antiproliferative and antitumorigenic activities. However, little is known about the molecular mechanisms behind these biological properties. Aiming to identify proteins involved in the Ang-(1-7) signaling, we performed a mass spectrometry-based time-resolved quantitative phosphoproteome study of human aortic endothelial cells (HAEC) treated with Ang-(1-7). We identified 1288 unique phosphosites on 699 different proteins with 99% certainty of correct peptide identification and phosphorylation site localization. Of these, 121 sites on 79 proteins had their phosphorylation levels significantly changed by Ang-(1-7). Our data suggest that the antiproliferative activity of Ang-(1-7) is due to the activation or inactivation of several target phosphoproteins, such as forkhead box protein O1 (FOXO1), mitogen-activated protein kinase 1 (MAPK), proline-rich AKT1 substrate 1 (AKT1S1), among others. In addition, the antitumorigenic activity of Ang-(1-7) is at least partially due to FOXO1 activation, since we show that this transcriptional factor is activated and accumulated in the nucleus of A549 lung adenocarcinoma cells treated with Ang-(1-7). Moreover, Ang-(1-7) triggered changes in the phosphorylation status of several known downstream effectors of the insulin signaling, indicating an important role of Ang-(1-7) in glucose homeostasis. In summary, this study provides new concepts and new understanding of the Ang-(1-7) signal transduction, shedding light on the mechanisms underlying Mas activation.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 056587761

Download citation: RISBibTeXText

PMID: 22497526

DOI: 10.1021/pr3001755


Related references

Quantitative phosphoproteomics unveils temporal dynamics of thrombin signaling in human endothelial cells. Blood 123(12): E22-E36, 2014

Quantitative global phosphoproteomics of human umbilical vein endothelial cells after activation of the Rap signaling pathway. Molecular Biosystems 9(4): 732-749, 2013

Quantitative phosphoproteomics to characterize signaling networks. Seminars in Cell & Developmental Biology 23(8): 863-871, 2013

Global effects of kinase inhibitors on signaling networks revealed by quantitative phosphoproteomics. Molecular & Cellular Proteomics 8(12): 2796-2808, 2010

Quantitative proteomics and phosphoproteomics reveal novel insights into complexity and dynamics of the EGFR signaling network. Proteomics 8(21): 4383-4401, 2008

Quantitative phosphoproteomics analysis reveals broad regulatory role of heparan sulfate on endothelial signaling. Molecular & Cellular Proteomics 12(8): 2160-2173, 2014

Angiotensin-(1-7) counterregulates angiotensin II signaling in human endothelial cells. Hypertension 50(6): 1093-1098, 2007

Quantitative phosphoproteomics of cytotoxic T cells to reveal protein kinase d 2 regulated networks. Molecular & Cellular Proteomics 13(12): 3544-3557, 2015

Understanding the mechanisms of angiotensin II signaling involved in hypertension and its long-term sequelae: insights from Bartter's and Gitelman's syndromes, human models of endogenous angiotensin II signaling antagonism. Journal of Hypertension 32(11): 2109-19; Discussion 2119, 2016

Quantitative phosphoproteomics of transforming growth factor-β signaling in colon cancer cells. Proteomics 11(16): 3390-3401, 2011

Analysis of EGFR signaling pathway in nasopharyngeal carcinoma cells by quantitative phosphoproteomics. Proteome Science 9: 35-35, 2011

Phosphoproteomics: new insights into cellular signaling. Genome Biology 6(9): 230-230, 2005

Identification of intracellular proteins and signaling pathways in human endothelial cells regulated by angiotensin-(1-7). Journal of Proteomics 130: 129-139, 2016

Identification of novel signaling components in genistein-regulated signaling pathways by quantitative phosphoproteomics. Journal of Proteomics 75(2): 695-707, 2012

Quantitative phosphoproteomics reveals the protein tyrosine kinase Pyk2 as a central effector of olfactory receptor signaling in prostate cancer cells. Biochimica et Biophysica Acta 1854(6): 632-640, 2015